Selected article for: "ace angiotensin ii axis and acute respiratory syndrome"

Author: Liu, Li-Ping; Zhang, Xiao-Li; Li, Jian
Title: New perspectives on angiotensin-converting enzyme 2 and its related diseases
  • Cord-id: mz4286bl
  • Document date: 2021_6_15
  • ID: mz4286bl
    Snippet: Since the worldwide outbreak of coronavirus disease 2019, angiotensin-converting enzyme 2 (ACE2) has received widespread attention as the cell receptor of the severe acute respiratory syndrome coronavirus 2 virus. At the same time, as a key enzyme in the renin-angiotensin-system, ACE2 is considered to be an endogenous negative regulator of vasoconstriction, proliferation, fibrosis, and proinflammation caused by the ACE-angiotensin II-angiotensin type 1 receptor axis. ACE2 is now implicated as be
    Document: Since the worldwide outbreak of coronavirus disease 2019, angiotensin-converting enzyme 2 (ACE2) has received widespread attention as the cell receptor of the severe acute respiratory syndrome coronavirus 2 virus. At the same time, as a key enzyme in the renin-angiotensin-system, ACE2 is considered to be an endogenous negative regulator of vasoconstriction, proliferation, fibrosis, and proinflammation caused by the ACE-angiotensin II-angiotensin type 1 receptor axis. ACE2 is now implicated as being closely connected to diabetes, cardiovascular, kidney, and lung diseases, and so on. This review covers the available information on the host factors regulating ACE2 and discusses its role in a variety of pathophysiological conditions in animal models and humans.

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and acei treatment: 1, 2, 3
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute lung injury: 1, 2, 3, 4
    • ace inhibitor and adipose tissue: 1
    • acei arb treatment and acute ards respiratory distress syndrome: 1
    • acei arb treatment and acute lung injury: 1
    • acei treatment and acute ards respiratory distress syndrome: 1
    • acei treatment and acute lung injury: 1, 2
    • acid aspiration and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acid aspiration and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • activity mrna level and acute lung injury: 1
    • acute ards respiratory distress syndrome and additional benefit: 1, 2
    • acute ards respiratory distress syndrome and adipose tissue: 1, 2, 3, 4
    • acute lung injury and adipose tissue: 1, 2
    • acute lung injury protective role and adipose tissue: 1